Marinomed: Anti-viral medication from Vienna to receive Houska Award worth 150,000 euros

Marinomed develops therapies against respiratory diseases using its innovative antiviral respiratory technology platform, MAVIREX. Its successful products won over the jury that selected the winners of the Houska Award, which is Austria’s largest privately funded research award granted by the B&C Privatstiftung. 

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)